241 related articles for article (PubMed ID: 29241809)
21. End-of-life care in Medicare beneficiaries dying with pancreatic cancer.
Sheffield KM; Boyd CA; Benarroch-Gampel J; Kuo YF; Cooksley CD; Riall TS
Cancer; 2011 Nov; 117(21):5003-12. PubMed ID: 21495020
[TBL] [Abstract][Full Text] [Related]
22. Trends in end-of-life cancer care in the Medicare program.
Wang SY; Hall J; Pollack CE; Adelson K; Bradley EH; Long JB; Gross CP
J Geriatr Oncol; 2016 Mar; 7(2):116-25. PubMed ID: 26783015
[TBL] [Abstract][Full Text] [Related]
23. Changes in Medicare costs with the growth of hospice care in nursing homes.
Gozalo P; Plotzke M; Mor V; Miller SC; Teno JM
N Engl J Med; 2015 May; 372(19):1823-31. PubMed ID: 25946281
[TBL] [Abstract][Full Text] [Related]
24. Patterns of Care and Costs for Older Patients With Colorectal Cancer at the End of Life: Descriptive Study of the United States and Canada.
Bremner KE; Yabroff KR; Coughlan D; Liu N; Zeruto C; Warren JL; de Oliveira C; Mariotto AB; Lam C; Barrett MJ; Chan KK; Hoch JS; Krahn MD
JCO Oncol Pract; 2020 Jan; 16(1):e1-e18. PubMed ID: 31647697
[TBL] [Abstract][Full Text] [Related]
25. Family Perspectives on Aggressive Cancer Care Near the End of Life.
Wright AA; Keating NL; Ayanian JZ; Chrischilles EA; Kahn KL; Ritchie CS; Weeks JC; Earle CC; Landrum MB
JAMA; 2016 Jan; 315(3):284-92. PubMed ID: 26784776
[TBL] [Abstract][Full Text] [Related]
26. Associations Between End-of-Life Cancer Care Patterns and Medicare Expenditures.
Wang SY; Hall J; Pollack CE; Adelson K; Davidoff AJ; Long JB; Gross CP
J Natl Compr Canc Netw; 2016 Aug; 14(8):1001-8. PubMed ID: 27496116
[TBL] [Abstract][Full Text] [Related]
27. Polypharmacy, chemotherapy receipt, and medication-related out-of-pocket costs at end of life among commercially insured adults with advanced cancer.
McDermott CL; Curtis JR; Sun Q; Fedorenko C; Kreizenbeck K; Ramsey SD
J Oncol Pharm Pract; 2022 Jun; 28(4):836-841. PubMed ID: 33823685
[TBL] [Abstract][Full Text] [Related]
28. Impact of Hospice on Spending and Utilization Among Patients With Lung Cancer in Medicare.
Kalidindi Y; Segel J; Jung J
Am J Hosp Palliat Care; 2020 Apr; 37(4):286-293. PubMed ID: 31564110
[TBL] [Abstract][Full Text] [Related]
29. Costs of Cancer Care Across the Disease Continuum.
Kaye DR; Min HS; Herrel LA; Dupree JM; Ellimoottil C; Miller DC
Oncologist; 2018 Jul; 23(7):798-805. PubMed ID: 29567821
[TBL] [Abstract][Full Text] [Related]
30. The burden of health care costs for patients with dementia in the last 5 years of life.
Kelley AS; McGarry K; Gorges R; Skinner JS
Ann Intern Med; 2015 Nov; 163(10):729-36. PubMed ID: 26502320
[TBL] [Abstract][Full Text] [Related]
31. Cost-utility analysis of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer.
Lairson DR; Parikh RC; Cormier JN; Du XL
Value Health; 2014; 17(1):34-42. PubMed ID: 24438715
[TBL] [Abstract][Full Text] [Related]
32. Factors Affecting Racial Disparities in End-of-Life Care Costs Among Lung Cancer Patients: A SEER-Medicare-based Study.
Karanth S; Rajan SS; Revere FL; Sharma G
Am J Clin Oncol; 2019 Feb; 42(2):143-153. PubMed ID: 30300168
[TBL] [Abstract][Full Text] [Related]
33. Association Between Hospice Enrollment and Total Health Care Costs for Insurers and Families, 2002-2018.
Aldridge MD; Moreno J; McKendrick K; Li L; Brody A; May P
JAMA Health Forum; 2022 Feb; 3(2):e215104. PubMed ID: 35977281
[TBL] [Abstract][Full Text] [Related]
34. Association between survival time with metastatic breast cancer and aggressive end-of-life care.
Accordino MK; Wright JD; Vasan S; Neugut AI; Gross T; Hillyer GC; Hershman DL
Breast Cancer Res Treat; 2017 Nov; 166(2):549-558. PubMed ID: 28752188
[TBL] [Abstract][Full Text] [Related]
35. The Relationship Between Guideline-Recommended Initiation of Therapy, Outcomes, and Cost for Patients with Metastatic Non-Small Cell Lung Cancer.
Casebeer A; Antol DD; DeClue RW; Hopson S; Li Y; Khoury R; Michael T; Sehman M; Parikh A; Stemkowski S; Bunce M
J Manag Care Spec Pharm; 2018 Jun; 24(6):554-564. PubMed ID: 29799325
[TBL] [Abstract][Full Text] [Related]
36. Can primary care visits reduce hospital utilization among Medicare beneficiaries at the end of life?
Kronman AC; Ash AS; Freund KM; Hanchate A; Emanuel EJ
J Gen Intern Med; 2008 Sep; 23(9):1330-5. PubMed ID: 18506545
[TBL] [Abstract][Full Text] [Related]
37. Resource Use and Medicare Costs During Lay Navigation for Geriatric Patients With Cancer.
Rocque GB; Pisu M; Jackson BE; Kvale EA; Demark-Wahnefried W; Martin MY; Meneses K; Li Y; Taylor RA; Acemgil A; Williams CP; Lisovicz N; Fouad M; Kenzik KM; Partridge EE;
JAMA Oncol; 2017 Jun; 3(6):817-825. PubMed ID: 28125760
[TBL] [Abstract][Full Text] [Related]
38. The economic burden of end-of-life care in metastatic breast cancer.
Bramley T; Antao V; Lunacsek O; Hennenfent K; Masaquel A
J Med Econ; 2016 Nov; 19(11):1075-1080. PubMed ID: 27248201
[TBL] [Abstract][Full Text] [Related]
39. Association Between Hearing Aid Use and Health Care Use and Cost Among Older Adults With Hearing Loss.
Mahmoudi E; Zazove P; Meade M; McKee MM
JAMA Otolaryngol Head Neck Surg; 2018 Jun; 144(6):498-505. PubMed ID: 29710214
[TBL] [Abstract][Full Text] [Related]
40. Relationship between use of general practice and healthcare costs at the end of life: a data linkage study in New South Wales, Australia.
Tran B; Falster MO; Girosi F; Jorm L
BMJ Open; 2016 Jan; 6(1):e009410. PubMed ID: 26743704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
